Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Krebs

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
NPJ Precision Oncology|March 26, 2025
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patientsJulio Herrero Colomina, Eleanor Johnston, Kate Duffus, et al.
The American Journal of Pathology|March 2, 2011
Circulating tumor cells as a window on metastasis biology in lung cancerJian-Mei Hou, Matthew Krebs, Tim Ward, et al.
The Oncologist|July 12, 2019
Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced CancerNadina Tinsley, Cong Zhou, Grace Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell CarcinomaMartin Forster, Irene Brana, Antonio L Pousa, et al.
The American Journal of Pathology|July 25, 2009
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapyJian-Mei Hou, Alastair Greystoke, Lee Lancashire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control studyRuth L Katz, Weigong He, Abha Khanna, et al.
Clinical and Translational Radiation Oncology|October 19, 2020
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancerGerard M Walls, Jamie B Oughton, Anthony J Chalmers, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
NPJ Precision Oncology|March 26, 2025
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patientsJulio Herrero Colomina, Eleanor Johnston, Kate Duffus, et al.
The American Journal of Pathology|March 2, 2011
Circulating tumor cells as a window on metastasis biology in lung cancerJian-Mei Hou, Matthew Krebs, Tim Ward, et al.
The Oncologist|July 12, 2019
Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced CancerNadina Tinsley, Cong Zhou, Grace Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell CarcinomaMartin Forster, Irene Brana, Antonio L Pousa, et al.
The American Journal of Pathology|July 25, 2009
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapyJian-Mei Hou, Alastair Greystoke, Lee Lancashire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control studyRuth L Katz, Weigong He, Abha Khanna, et al.
Clinical and Translational Radiation Oncology|October 19, 2020
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancerGerard M Walls, Jamie B Oughton, Anthony J Chalmers, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Pageof 2